What Is the Best Preoperative Imaging for Endometrial Cancer? (Q28077761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

1 September 2020

What Is the Best Preoperative Imaging for Endometrial Cancer? (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

local neoplasm recurrence

9 March 2020

main subject

2 references

3 April 2019

1 September 2020

2 references

1 September 2020

2 references

1 September 2020

1 reference

26922331

language of work or name

1 reference

1 April 2016

6 references

13 March 2019

14 March 2019

24 March 2019

3 April 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 September 2020

Current Oncology Reports

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

29 May 2020

1 September 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

9 March 2020

5 references

13 March 2019

14 March 2019

24 March 2019

3 April 2019

on focus list of Wikimedia project

1 September 2020

copyrighted

0 references

ScienceSource

0 references

cites work

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Hypoxia in cancer: significance and impact on clinical outcome

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Quantifying tumour heterogeneity with CT

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Molecular mechanisms and clinical applications of angiogenesis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Transvaginal/transrectal ultrasound for assessing myometrial invasion in endometrial cancer: a comparison of six different approaches

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Transvaginal ultrasound for preoperative assessment of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Gynecologic oncologic imaging with PET/CT.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Molecular imaging in the management of gynecologic malignancies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Can magnetic resonance spectroscopy differentiate endometrial cancer?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Markers for individualised therapy in endometrial carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma—Relationship with local invasiveness

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Three-dimensional ultrasound for assessing women with gynecological cancer: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Use of new imaging techniques to predict tumour response to therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Assessing myometrial infiltration by endometrial cancer: uterine virtual navigation with three-dimensional US.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

PET and PET-CT imaging of gynecological malignancies: present role and future promise

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Staging endometrial cancer: role of magnetic resonance imaging

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Radiologic staging in patients with endometrial cancer: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Tumor size in endometrial cancer

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4769723

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

2 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Intratumoral blood flow analysis in endometrial carcinoma: correlation with tumor characteristics and risk for recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Comparative Performance of the 2009 International Federation of Gynecology and Obstetricsʼ Staging System for Uterine Corpus Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Tumor volume successively reflects the state of disease progression in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Magnetic resonance spectroscopy of premalignant and malignant endometrial disorders: a feasibility of in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Can the signal-to-noise ratio of choline in magnetic resonance spectroscopy reflect the aggressiveness of endometrial cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: comparison with imaging at 1.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-016-0506-0

Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?

21 January 2018

1 reference

12 December 2020

Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer

1 reference

12 December 2020

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer

1 reference

12 December 2020

Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification

1 reference

12 December 2020

Factors affecting sonographic preoperative local staging of endometrial cancer

1 reference

12 December 2020

Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma

1 reference

12 December 2020

Pretreatment assessment of prognostic indicators in endometrial cancer

1 reference

12 December 2020

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Prognostic significance of hormone receptors in endometrial cancer

1 reference

12 December 2020

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer

1 reference

12 December 2020

1 reference

12 December 2020

Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma

1 reference

12 December 2020

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

12 December 2020

Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting

1 reference

12 December 2020

Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T

1 reference

12 December 2020

Three-dimensional power Doppler angiography in endometrial cancer: correlation with tumor characteristics

1 reference

12 December 2020

10.1007/S11912-016-0506-0

Identifiers

DOI

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 March 2020

1035042153

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

26922331

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26922331%20AND%20SRC:MED&resulttype=core&format=json